Medical & Biological Laboratories Co., Ltd. researches, develops, manufactures, and sells in vitro diagnostics and research reagents worldwide. It offers in vitro diagnostics for allergies, autoimmune skin diseases, novel coronavirus, and polymyositis/dermatomyositis. The company was founded in 1969 and is headquartered in Nagoya, Japan. Medical & Biological Laboratories Co., Ltd. is a subsidiary of JSR Life Sciences, LLC.
Research context
Medical & Biological Laboratories Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Medical & Biological Laboratories Co., Ltd is currently in a long term uptrend where the price is trading 17.5% above its 200 day moving average.
From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Medical & Biological Laboratories Co., Ltd's total revenue rose by 19.6% to $3B since the same quarter in the previous year.
Its net income has increased by 137.9% to $596M since the same quarter in the previous year.
Based on the above factors, Medical & Biological Laboratories Co., Ltd gets an overall score of 4/5.